BDBM304697 4-((S)-3-isopropyl-4-(((1s,4R)-4-(trifluoromethyl)cyclohexyl)methyl)piperazin-1-yl)-2-(methylsulfonyl)benzonitrile::US10144715, Compound 50-1

SMILES: CC(C)[C@H]1CN(CCN1C[C@H]1CC[C@H](CC1)C(F)(F)F)c1ccc(C#N)c(c1)S(C)(=O)=O

InChI Key: InChIKey=WLYJUBOVJNVBDO-SLYNCCJLSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 304697   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Oxysterols receptor LXR-beta (Homo sapiens (Human))	BDBM304697 (4-((S)-3-isopropyl-4-(((1s,4R)-4-(trifluoromethyl)...) Show SMILES CC(C)[C@H]1CN(CCN1C[C@H]1CC[C@H](CC1)C(F)(F)F)c1ccc(C#N)c(c1)S(C)(=O)=O |r,wU:10.10,13.17,wD:3.2,(5.51,-26.58,;4.17,-25.81,;2.84,-26.58,;4.17,-24.27,;5.51,-23.5,;5.51,-21.96,;4.17,-21.19,;2.84,-21.96,;2.84,-23.5,;1.51,-24.27,;.17,-23.5,;-1.16,-24.27,;-2.5,-23.5,;-2.5,-21.96,;-1.16,-21.19,;.17,-21.96,;-3.83,-21.19,;-5.16,-21.96,;-3.83,-19.65,;-3.83,-22.73,;6.84,-21.19,;8.17,-21.96,;9.51,-21.19,;9.54,-19.62,;10.88,-18.87,;12.23,-18.11,;8.18,-18.84,;6.84,-19.65,;8.17,-17.3,;9.71,-17.28,;8.15,-15.76,;6.63,-17.32,)| Show InChI InChI=1S/C23H32F3N3O2S/c1-16(2)21-15-28(20-9-6-18(13-27)22(12-20)32(3,30)31)10-11-29(21)14-17-4-7-19(8-5-17)23(24,25)26/h6,9,12,16-17,19,21H,4-5,7-8,10-11,14-15H2,1-3H3/t17-,19+,21-/m1/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	6	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, Inc. US Patent					Assay Description Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...				US Patent US10144715 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NFD
					More data for this Ligand-Target Pair
Oxysterols receptor LXR-alpha (Homo sapiens (Human))	BDBM304697 (4-((S)-3-isopropyl-4-(((1s,4R)-4-(trifluoromethyl)...) Show SMILES CC(C)[C@H]1CN(CCN1C[C@H]1CC[C@H](CC1)C(F)(F)F)c1ccc(C#N)c(c1)S(C)(=O)=O |r,wU:10.10,13.17,wD:3.2,(5.51,-26.58,;4.17,-25.81,;2.84,-26.58,;4.17,-24.27,;5.51,-23.5,;5.51,-21.96,;4.17,-21.19,;2.84,-21.96,;2.84,-23.5,;1.51,-24.27,;.17,-23.5,;-1.16,-24.27,;-2.5,-23.5,;-2.5,-21.96,;-1.16,-21.19,;.17,-21.96,;-3.83,-21.19,;-5.16,-21.96,;-3.83,-19.65,;-3.83,-22.73,;6.84,-21.19,;8.17,-21.96,;9.51,-21.19,;9.54,-19.62,;10.88,-18.87,;12.23,-18.11,;8.18,-18.84,;6.84,-19.65,;8.17,-17.3,;9.71,-17.28,;8.15,-15.76,;6.63,-17.32,)| Show InChI InChI=1S/C23H32F3N3O2S/c1-16(2)21-15-28(20-9-6-18(13-27)22(12-20)32(3,30)31)10-11-29(21)14-17-4-7-19(8-5-17)23(24,25)26/h6,9,12,16-17,19,21H,4-5,7-8,10-11,14-15H2,1-3H3/t17-,19+,21-/m1/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	107	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, Inc. US Patent					Assay Description Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...				US Patent US10144715 (2018) BindingDB Entry DOI: 10.7270/Q2PV6NFD
					More data for this Ligand-Target Pair